Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Am Coll Nutr ; 38(3): 197-208, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30247998

RESUMEN

The most recent scientific evidence supports the consumption of cow's milk and dairy products as part of a balanced diet. However, these days, the public and practicing physicans are exposed to a stream of inconsistent (and often misleading) information regarding the relationship between cow's milk intake and health in the lay press and in the media. The purpose of this article, in this context, is to facilitate doctor-patient communication on this topic, providing physicians with a series of structured answers to frequently asked patient questions. The answers range from milk and milk-derived products' nutritional function across the life span, to their relationship with diseases such as osteoporosis and cancer, to lactose intolerance and milk allergy, and have been prepared by a panel of experts from the Italian medical and nutritional scientific community. When consumed according to appropriate national guidelines, milk and its derivatives contribute essential micro- and macronutrients to the diet, especially in infancy and childhood where bone mass growth is in a critical phase. Furthermore, preliminary evidence suggests potentially protective effects of milk against overweight, obesity, diabetes, and cardiovascular disease, while no clear data suggest a significant association between milk intake and cancer. Overall, current scientific literature suggests that an appropriate consumption of milk and its derivatives, according to available nutritional guidelines, may be beneficial across all age groups, with the exception of specific medical conditions such as lactose intolerance or milk protein allergy. Key teaching points: Milk and its derivatives contribute essential micro and macronutrients to the diet, when consumed according to appropriate national guidelines, especially in infancy and childhood where bone mass growth is in a critical phase. Preliminary evidence suggests potentially protective effects of milk against overweight, obesity, diabetes and cardiovascular disease No clear data are available about the association between milk intake and cancer. Current scientific literature suggests that an appropriate consumption of milk and its derivatives may be beneficial at all ages, with the exception of specific medical conditions such as lactose intolerance or milk protein allergy.


Asunto(s)
Dieta , Leche , Valor Nutritivo , Animales , Bovinos , Hipersensibilidad a los Alimentos , Humanos
2.
Eur Heart J Suppl ; 19(Suppl D): D293-D308, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28751847

RESUMEN

The new oral anticoagulants (NOACs) have radically changed the approach to the treatment and prevention of thromboembolic pulmonary embolism. The authors of this position paper face, in succession, issues concerning NOACs, including (i) their mechanism of action, pharmacodynamics, and pharmacokinetics; (ii) the use in the acute phase with the 'double drug single dose' approach or with 'single drug double dose'; (iii) the use in the extended phase with demonstrated efficacy and with low incidence of bleeding events; (iv) the encouraging use of NOACs in particular subgroups of patients such as those with cancer, the ones under- or overweight, with renal insufficiency (creatinine clearance > 30 mL/min), the elderly (>75 years); (v) they propose a possible laboratory clinical pathway for follow-up; and (vi) carry out an examination on the main drug interactions, their potential bleeding risk, and the way to deal with some bleeding complications. The authors conclude that the use of NOACs both in the acute phase and in the extended phase is equally effective to conventional therapy and associated with fewer major bleeding events, which make their use in patients at higher risk of recurrences safer.

3.
Biomimetics (Basel) ; 8(2)2023 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-37092396

RESUMEN

The design of a flapping fins stabilization system for yachts at anchor (zero speed conditions) is presented in this study. The solution presented in this manuscript took inspiration from a solution proposed for the design of a biologically inspired flapping UAV. Although the application was different, we used the same principles and methodology to design and study the stabilization mechanism discussed hereafter. The proposed system uses flapping fins to damp the roll oscillations of the vessel, and when the stabilization system is retracted, the surface of each of the fins is flush with the hull, thus offering minimum resistance when the ship is in cruise conditions. The unsteady forces of the flapping fins were computed using computational fluid dynamics, and they were used as input to conduct the structural and durability study of the proposed mechanism. The vessel's response to roll perturbations was also studied, using a multi-body dynamics approach. From the results obtained, and the design specifications defined, it was found that the response of the stabilization system was acceptable, and that the mechanism could withstand the inertial and hydrodynamic loads.

4.
Europace ; 14(11): 1661-5, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22544910

RESUMEN

AIMS: The aims of the study are to develop a cost-minimization analysis from the hospital perspective and a cost-effectiveness analysis from the third payer standpoint, based on direct estimates of costs and QOL associated with remote follow-ups, using Merlin@home and Merlin.net, compared with standard ambulatory follow-ups, in the management of ICD and CRT-D recipients. METHODS AND RESULTS: Remote monitoring systems can replace ambulatory follow-ups, sparing human and economic resources, and increasing patient safety. TARIFF is a prospective, controlled, observational study aimed at measuring the direct and indirect costs and quality of life (QOL) of all participants by a 1-year economic evaluation. A detailed set of hospitalized and ambulatory healthcare costs and losses of productivity that could be directly influenced by the different means of follow-ups will be collected. The study consists of two phases, each including 100 patients, to measure the economic resources consumed during the first phase, associated with standard ambulatory follow-ups, vs. the second phase, associated with remote follow-ups. CONCLUSION: Remote monitoring systems enable caregivers to better ensure patient safety and the healthcare to limit costs. TARIFF will allow defining the economic value of remote ICD follow-ups for Italian hospitals, third payers, and patients. The TARIFF study, based on a cost-minimization analysis, directly comparing remote follow-up with standard ambulatory visits, will validate the cost effectiveness of the Merlin.net technology, and define a proper reimbursement schedule applicable for the Italian healthcare system. TRIAL REGISTRATION: NCT01075516.


Asunto(s)
Dispositivos de Terapia de Resincronización Cardíaca/economía , Terapia de Resincronización Cardíaca/economía , Desfibriladores Implantables/economía , Cardioversión Eléctrica/economía , Costos de la Atención en Salud , Monitoreo Ambulatorio/economía , Proyectos de Investigación , Telemedicina/economía , Telemetría/economía , Atención Ambulatoria/economía , Terapia de Resincronización Cardíaca/efectos adversos , Dispositivos de Terapia de Resincronización Cardíaca/efectos adversos , Distribución de Chi-Cuadrado , Ahorro de Costo , Análisis Costo-Beneficio , Desfibriladores Implantables/efectos adversos , Cardioversión Eléctrica/efectos adversos , Cardioversión Eléctrica/instrumentación , Costos de Hospital , Humanos , Reembolso de Seguro de Salud , Italia , Modelos Económicos , Monitoreo Ambulatorio/instrumentación , Valor Predictivo de las Pruebas , Estudios Prospectivos , Calidad de Vida , Sistema de Registros , Telemedicina/instrumentación , Telemetría/instrumentación , Factores de Tiempo , Resultado del Tratamiento
5.
Europace ; 10(8): 918-25, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18541620

RESUMEN

AIMS: Morphology discrimination (MD) is an algorithm based on QRS morphology analysis, that can be used alone or in various combinations with other discriminators in order to diagnose ventricular tachycardia (VT) [the implantable cardioverter-defibrillator (ICD) may be set to diagnose VT if 'Any' or 'All' the discriminators indicate VT)]. METHODS AND RESULTS: We evaluated the contribution of MD in terms of Specificity (SP) and Sensitivity (SE) of rhythm discrimination in slow and fast VT zones (rates <150 bpm and between 150 and 180 bpm, respectively). Detection results (682 spontaneous episodes in 58 patients) were corrected for multiple episodes within a patient (generalized estimating equations method). Rhythm discrimination in slow VT zones was characterized by SE and SP below 80% without MD, while the use of MD alone allowed to enhance SP, maintaining SE at 96%. Use of MD in combination with other discriminators resulted in a decrease in SP (setting 'Any'). In fast VT zones, MD allows an increase in SE for VT detection from around 82% up to approximately 94%, coupled with an SP of 95-96%., although SP is much higher with MD alone (94.8%) than with any other combination (78.4%). Both in slow and fast VT zones, use of multiple discriminators with the setting 'All' resulted in an unacceptable decrease in SE. CONCLUSION: MD in a dual-chamber ICD in combination with a rate branch classification system makes it possible to achieve a very high SP in discriminating detected events both in slow and fast VT zones, while maintaining SE for VT detection.


Asunto(s)
Algoritmos , Desfibriladores Implantables , Diagnóstico por Computador/métodos , Electrocardiografía/métodos , Taquicardia Ventricular/diagnóstico , Taquicardia Ventricular/prevención & control , Terapia Asistida por Computador/métodos , Anciano , Análisis Discriminante , Femenino , Humanos , Masculino , Reconocimiento de Normas Patrones Automatizadas/métodos , Resultado del Tratamiento
6.
G Ital Cardiol (Rome) ; 19(9): 504-509, 2018 Sep.
Artículo en Italiano | MEDLINE | ID: mdl-30087511

RESUMEN

BACKGROUND: Cardiovascular risk stratification and perioperative management of subjects undergoing non-cardiac surgery have recently been updated in the 2014 European Society of Cardiology guidelines. Nevertheless, and notwithstanding the epidemiological relevance of this condition, an underevaluation of the importance of perioperative risk stratification is a common feeling. METHODS: The ANMCO Cardiovascular Prevention Area organized, last year, a web-based survey with 15 questions to investigate perioperative management and care pathways in non-cardiac surgery and to evaluate guideline adherence of Italian cardiologists. Participation in the survey was anonymous. RESULTS: Respondents had a homogeneous geographical, as well as working (coronary care unit, post-intensive care unit, ambulatory service) distribution. Among respondents, 38% evaluated more than 20 patients each month, and 25% more than 20 patients aged >75 years. Local diagnostic guidelines were available according to 60% of respondents. Despite guideline recommendations, cardiological evaluation preceded the anesthesiologic one according to 36% of respondents, and 42% reported that it was performed independent of baseline risk. In addition, perioperative use of risk scores was low (1%), and functional capacity was reported from only 56% of respondents. Half of them used bridge therapy with heparin after stopping direct oral anticoagulants. CONCLUSIONS: The results of the ANMCO web-based survey confirm the need to promote educational programs on risk stratification and to raise awareness of Italian cardiologists on this matter in order to improve guideline adherence.


Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Adhesión a Directriz/estadística & datos numéricos , Guías de Práctica Clínica como Asunto , Procedimientos Quirúrgicos Operativos/métodos , Anciano , Anticoagulantes/administración & dosificación , Cardiólogos/estadística & datos numéricos , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/etiología , Encuestas de Atención de la Salud , Humanos , Italia , Atención Perioperativa/métodos , Medición de Riesgo/métodos , Factores de Riesgo
7.
J Cardiovasc Electrophysiol ; 18(7): 728-34, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17504256

RESUMEN

OBJECTIVES: To evaluate the possible pain reduction of the plateau waveform in atrial fibrillation (AF) patients. BACKGROUND: Previous studies have indicated that reduced amplitude waveforms would be less painful than a conventional (65/65% tilt) biphasic waveform. Computer modeling suggested that a moderately long (10-12 msec) plateau (flat topped) shock waveform would deliver equivalent effectiveness with the lowest possible peak amplitude. METHODS: We enrolled 27 patients at two sites with persistent AF with a total of 220 shocks delivered during internal atrial cardioversion using an interleaved crossover design. Patient response was scored in three ways: (1) a verbally reported discomfort score, (2) visual analog scale (VAS), and (3) a blinded observer reporting a contraction score. RESULTS: All scores were significantly reduced (P < 0.0001) by the plateau waveform with impressive statistics: Verbal discomfort (3.51 +/- 0.13 to 2.89 +/- 0.12), VAS (7.00 +/- 0.56 to 5.91 +/- 0.36), and contraction scores (1.94 +/- 0.12 to 1.62 +/- 0.12). The average pain threshold shift (TS) for the Verbal score was 2.34, while that for the VAS score was 2.30. (This means that the patient typically could tolerate 2.34 times as much energy with the plateau waveform for the same level of verbally reported discomfort.) The contraction TS was less at 1.57. Response scores were also corrected for the shock sequence number to control for the sensitization effect from multiple shocks. This increased the TS for the Verbal score to 3.58, but the shock number was not significant for the VAS. A pulmonary artery electrode return was associated with lower pain compared with a coronary sinus position. CONCLUSION: A plateau shaped biphasic waveform resulted in significantly increased shock energy pain tolerances. Controlling for session sensitization, patients tolerated over three times as much energy for the same verbally reported discomfort score.


Asunto(s)
Fibrilación Atrial/fisiopatología , Fibrilación Atrial/terapia , Cardioversión Eléctrica/métodos , Dimensión del Dolor , Anciano , Estudios Cruzados , Femenino , Humanos , Masculino , Persona de Mediana Edad , Dimensión del Dolor/métodos , Valor Predictivo de las Pruebas
8.
G Ital Cardiol (Rome) ; 17(9 Suppl 1): 29S-67, 2016 Sep.
Artículo en Italiano | MEDLINE | ID: mdl-27869892

RESUMEN

The new oral anticoagulants (NOACs) have radically changed the approach to the treatment and prevention of thromboembolic pulmonary embolism. The authors of this position paper face, in succession, issues concerning NOACs, including 1) their mechanism of action, pharmacodynamics and pharmacokinetics; 2) the use in the acute phase with the "double drug single dose" approach or with "single drug double dose"; 3) the use in the extended phase with demonstrated efficacy and with low incidence of bleeding events; 4) the encouraging use of NOACs in particular subgroups of patients such as those with cancer, the ones under- or overweight, with renal insufficiency (creatinine clearance >30 ml/min), the elderly (>75 years); 5) they propose a possible laboratory clinical pathway for follow-up; 6) carry out an examination on the main drug interactions, their potential bleeding risk, and the way to deal with some bleeding complications. The authors conclude that the use of NOACs both in the acute phase and in the extended phase is equally effective to conventional therapy and associated with fewer major bleeding events, which make their use in patients at higher risk of recurrences safer.


Asunto(s)
Anticoagulantes/administración & dosificación , Tromboembolia/prevención & control , Administración Oral , Anciano , Hemorragia , Humanos , Embolia Pulmonar , Tromboembolia/tratamiento farmacológico , Tromboembolia Venosa
9.
Heart Rhythm ; 2(7): 708-13, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15992726

RESUMEN

BACKGROUND: Shock pain has limited the acceptance of the implantable atrial cardioverter and is a complication of ventricular implantable cardioverter-defibrillator therapy. Rounding off of the peak of a shock waveform reduces pain. Whether the pain reduction results from reduction in the peak voltage or from the rounding has not been established. In other words, does reducing the extreme dV/dt (voltage derivative) of the conventional truncated exponential capacitive discharge waveform reduce pain? OBJECTIVES: The purpose of this study was to compare the relative contributions of peak voltage and waveform shape to pain. METHODS: We compared rounded and conventional waveforms with equal peak voltages. Eighty-five shocks of 50 to 500 V were delivered to 10 patients requiring atrial cardioversion for persistent atrial fibrillation. The patient touched an analog pain scale (0-15 cm) and orally reported a pain score on a scale from 0 to 5. An observer scored thoracic contractions on a scale from 0 to 5. RESULTS: No differences between the rounded and conventional waveform on any scale were noted for either univariate or multivariate analyses. However, all three response scales were strongly predicted by voltage with r(2) = 0.77 (oral), r(2) = 0.86 (analog), and r(2) = 0.85 (contraction) after correcting for patient variability and including a log voltage term. CONCLUSIONS: Patient pain perception was determined primarily by waveform peak voltage and not by the rounding, per se.


Asunto(s)
Fibrilación Atrial/terapia , Capacidad Eléctrica , Cardioversión Eléctrica/efectos adversos , Cardioversión Eléctrica/métodos , Dolor/etiología , Dolor/prevención & control , Adulto , Anciano , Desfibriladores Implantables , Humanos , Masculino , Persona de Mediana Edad , Dolor/fisiopatología , Dimensión del Dolor , Estudios Prospectivos
10.
Pacing Clin Electrophysiol ; 31(1): 56-63, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18181910

RESUMEN

INTRODUCTION: Although optimization of atrioventricular and interventricular delays has been demonstrated to improve hemodynamics in patients with cardiac resynchronization therapy (CRT), the required time-consuming procedure discourages its use in clinical practice. Recently, a new method for CRT optimization based on the intracardiac electrogram (IEGM) detected by the implanted leads, has been developed. We evaluated the effectiveness of this method in improving left ventricular (LV) asynchrony and performance using real-time 3D echocardiography (RT3DE). METHODS AND RESULTS: Twenty patients with CRT were prospectively studied. RT3DE was performed before and after IEGM optimization. The standard deviation of the time to the regional LV minimum systolic volume (Tmsv) for all 16 segments (Tmsv 16-SD), six basal and six mid segments (Tmsv 12-SD), and the six basal segments (Tmsv 6-SD) were assessed as a asynchrony indexes. LV end-diastolic and end-systolic volumes (EDV, ESV), stroke volume (SV), ejection fraction (EF), myocardial performance index (MPI), ejection time (ET), and filling time (FT), corrected by R-R interval, were also evaluated. After IEGM optimization, as compared with baseline Tmsv 12-SD and Tmsv 16-SD decreased (P = 0.01, P< 0.001, respectively), EF and SV improved (P < 0.001, P = 0.01 respectively), FT/RR and ET/RR increased (P = 0.02 for both), and MPI improved (P < 0.001). Tmsv 6-SD, EDV and ESV did not change. CONCLUSION: A simple IEGM-based method of CRT optimization decreased LV dyssynchrony and improved systolic function.


Asunto(s)
Estimulación Cardíaca Artificial/normas , Ecocardiografía Tridimensional , Isquemia Miocárdica/diagnóstico por imagen , Isquemia Miocárdica/terapia , Marcapaso Artificial , Disfunción Ventricular Izquierda/diagnóstico por imagen , Disfunción Ventricular Izquierda/terapia , Anciano , Algoritmos , Humanos , Masculino , Estudios Prospectivos , Estadísticas no Paramétricas
11.
Europace ; 7(3): 255-65, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15878565

RESUMEN

BACKGROUND: Devices for cardiac resynchronisation therapy (CRT) deliver energy into 3 output channels. Such a burden can significantly reduce device longevity. Autocapture has been shown to improve pacemaker longevity and safety of right ventricular pacing in clinical studies. The aim of this study was to investigate the application of Autocapture during biventricular pacing (BIV) to decrease the energy cost of CRT. METHODS: During implantation of BIV devices, an acute study was performed to test the hypothesis that the evoked response (ER) elicited by each delivered stimulus is correctly detected and measured either on the right ventricular (RV) channel during BIV pacing with the left ventricular (LV) channel pacing first, or in the LV channel with the RV channel pacing first. A reliable measurement of ER is the critical requirement for the correct performance of Autocapture. RESULTS: ER amplitude in the right ventricle during BIV pacing was not significantly decreased compared with RV pacing in the VVI mode (16.36+/-5.27 mV vs 17.09+/-6.12 mV). ER amplitude in the left ventricle during BIV pacing was not significantly decreased compared with LV pacing in the VVI mode (12.4+/-8.95 mV vs 12.25+/-8.97 mV). Three patients in atrial fibrillation had a DDDR pacemaker with the LV lead connected to the atrial port, and received BIV pacing with Autocapture turned on in the RV channel. Autocapture performance in the long term, as assessed by the trend of RV threshold over 20+/-8 months, showed that LV depolarisation was never sensed as an ER on the RV channel. CONCLUSIONS: Our observations support the feasibility and safety of capture verification during BIV pacing on the ventricular channel paced secondly, which could increase the longevity of CRT devices, and decrease the costs of this new therapy for heart failure patients.


Asunto(s)
Estimulación Cardíaca Artificial/métodos , Insuficiencia Cardíaca/terapia , Algoritmos , Fibrilación Atrial , Electrocardiografía , Electrodos Implantados , Potenciales Evocados , Estudios de Factibilidad , Humanos , Marcapaso Artificial , Función Ventricular Izquierda , Función Ventricular Derecha
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA